Cite
MLA Citation
Takashi Seto et al.. “Phase II study of atezolizumab with bevacizumab for non-squamous non-small cell lung cancer with high PD-L1 expression (@Be Study).” Journal for immunotherapy of cancer, vol. 10, no. 2, 2022, p. . http://access.bl.uk/ark:/81055/vdc_100150523910.0x000009